Only about 1 in 4 people with sarcoidosis were referred to a lung specialist within a year of diagnosis,…
Articles by Margarida Maia, PhD
Sarcoidosis appears to involve activation of several immune pathways, particularly those guiding responses against some common viruses. These are…
The Foundation for Sarcoidosis Research (FSR) marks 25 years of work to help people with sarcoidosis live better…
EFZO-FIT, a Phase 3 clinical study testing efzofitimod for pulmonary sarcoidosis, failed to meet its main goal of significantly…
The final participant has completed the last visit as part of EFZO-FIT, a Phase 3 clinical trial testing Atyr Pharma’s experimental…
The first participants in a Phase 2 clinical trial testing brepocitinib, Roivant’s experimental oral treatment, in adults with cutaneous…
Methotrexate appears to take longer to start acting, but is no less effective than the corticosteroid prednisone as a first-line…
The Foundation for Sarcoidosis Research (FSR) is partnering with Walgreens and Cedars-Sinai to provide free N95 face masks at…
April is Sarcoidosis Awareness Month, and this year’s theme, as chosen by the Foundation for Sarcoidosis Research (FSR), is…
Enrollment is complete in the dose-finding phase of a Phase 1b/2b clinical trial evaluating Xentria’s investigational therapy XTMAB-16 in…